ralaniten ralaniten ralaniten (developmental code name epi-002) is an n-terminal domain antiandrogen which was never marketed. it is a derivative of bisphenol a and one of the four stereoisomers of epi-001. a prodrug of ralaniten, ralaniten acetate (epi-506), was under development for the treatment of prostate cancer. ralanitenclinical dataother namesepi-002drug classnonsteroidal antiandrogenidentifiers iupac name (2r)-3-phenyl]propan-2-yl]phenoxy]propane-1,2-diol cas number1203490-23-6pubchem cid45107537chemspider58827834uniiwc830g6o4xkeggd11184chemical and physical dataformulac21h27clo5molar mass394.89 g·mol−13d model (jsmol)interactive image smiles cc(c)(c1=cc=c(c=c1)oc(co)o)c2=cc=c(c=c2)oc(ccl)o inchi inchi=1s/c21h27clo5/c1-21(2,15-3-7-19(8-4-15)26-13-17(24)11-22)16-5-9-20(10-6-16)27-14-18(25)12-23/h3-10,17-18,23-25h,11-14h2,1-2h3/t17-,18-/m1/s1key:hdtyuhnzryzeeb-qztjidsgsa-n